Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
about
Omega-3 fatty acids: potential role in the management of early Alzheimer's diseaseAlzheimer's Disease associated with Psychiatric ComorbiditiesRole of methylglyoxal in Alzheimer's diseaseOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseGenetic markers in biological fluids for aging-related major neurocognitive disorderVitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysisTraumatic brain injury, neuroimaging, and neurodegenerationAPOE moderates the association between lifestyle activities and cognitive performance: evidence of genetic plasticity in aging.Biological markers and Alzheimer disease: a canadian perspectiveHeritability and genetic association analysis of neuroimaging measures in the Diabetes Heart StudyPresence of ApoE ε4 allele associated with thinner frontal cortex in middle age.The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease riskA review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion.Regulation of cerebral cholesterol metabolism in Alzheimer disease.APOE ε4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline.APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice.Concurrence of High Fat Diet and APOE Gene Induces Allele Specific Metabolic and Mental Stress Changes in a Mouse Model of Alzheimer's Disease.Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease developmentDementia, stroke, and vascular risk factors; a review.The Impact of Traumatic Brain Injury on the Aging Brain.Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia.Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice.Retracted: Advances in the physiological and pathological implications of cholesterol.Alzheimer's disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes.In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and PsychosociaApolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia.Dietary patterns and cognitive decline in an Australian study of ageing.25-hydroxyvitamin D, APOE ɛ4 genotype and cognitive function: findings from the 1958 British birth cohort.Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study.
P2860
Q24595490-925119FB-694A-4A4E-B5FF-0AD34D5966F0Q26796602-F6D8991D-1E8F-423B-91C1-E40D2CD047E4Q27004644-8EA26575-5990-4879-97F4-768049661C13Q27023315-D1E6456F-62B3-4364-83E8-79476D7E80D4Q27027348-353F747E-EF8A-47C3-AFF4-5F85F6FFBCCFQ28270239-CE4566CB-142C-45F9-A018-271335A098EEQ28386903-7AFA11A3-BEBD-4B91-9158-DD0617CB3C4FQ33895819-1CC5AFAE-5195-4C6E-B850-D749940FA310Q34089784-73C214BE-3EA8-4DD6-B0C5-B48C2084FCD8Q35137763-654EDC65-C716-422B-8089-F4CAAA7EE92AQ35825830-A91E710D-F883-4941-AE93-0D3ED0CFDBD3Q36007813-2979E0AA-9206-4170-897B-73088B1BD62CQ36520625-FEC3C49B-8CB2-4DFD-9D78-075572B0C7BBQ36841850-FB531A91-6380-4642-B711-F1B290D822F3Q36963331-5EDD017A-2093-46C5-9D84-9AB16C966E95Q37133286-5DDE81A3-B17C-4B26-8A93-34C4D4848DDAQ37231564-8C2BF36B-427A-450B-9C2D-59E827987390Q37268080-5C54AC87-7961-4B65-91A2-7B9C5F3F8A44Q37970511-2B754F26-4EB9-4610-B93B-6F58E7DBD4EBQ38901765-B3498EB1-838B-4BAD-9E64-B6350A5A9E8CQ39884498-B97D531A-41C2-4B93-81F8-8509EB871EDDQ41995767-DF5BBE2C-D5E9-4C09-A6BF-E67E254BEA4DQ42607789-80D0A341-D44D-4AF8-B62F-4E06BDC0360EQ46069993-EAEA5364-EC93-4F89-82FA-9D8204F7737FQ46650402-817EB579-6DE6-4F94-A148-41987A1E0400Q47564464-3F55EC35-4B2C-41DE-BFAC-770A92449E96Q47942810-D1E7A513-203E-4AA1-A9B9-A2AFD2FE7447Q48632790-602FD49A-6C76-4AF9-B8FB-6C37CADB0D55Q50630134-BC26321A-4C47-4669-88E0-1AC3609EE981Q55154216-8B3F039A-2D6B-4B30-9498-2C43A45BD577
P2860
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@ast
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@en
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@nl
type
label
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@ast
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@en
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@nl
prefLabel
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@ast
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@en
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@nl
P1476
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment.
@en
P2093
Hyman M Schipper
P304
P356
10.1016/J.NEUROBIOLAGING.2009.04.021
P577
2009-05-30T00:00:00Z